Comments on the proposed clinical trial regulatory arrangements

The Australia New Zealand Therapeutic Products Authority (ANZTPA) is calling for comments on its latest consultation paper.

The deadline for receipt of submissions on the Proposed clinical trial regulatory arrangements under ANZTPA is 18 April 2007.

Written comments will be accepted by post or email, and should contain cross-references to the specific sections set out in the consultation paper.

ANZTPA requires submissions to contain:

• Name and full contact details including: address, telephone number and, if applicable, facsimile and email address.
• The particular issue being addressed.
• Relevant evidence and/or examples to support the views expressed.
• In the case of organisations, the level at which the submission was authorised.

The full consultation paper and details on providing submissions can be viewed at www.anztpa.org.

Any questions relating to submissions should be directed to the clinical trials project officer at: consultation@anztpa.org.